China Biomaterials in Healthcare Market Report 2022 to 2030

China Biomaterials in Healthcare Market Analysis

$ 3999

The China Biomaterials Healthcare Market is expected to witness growth from $12.56 Bn in 2022 to $37.62 Bn in 2030 with a CAGR of 14.70% for the forecasted year 2022-2030. One of the world's biggest ageing populations is found in China. Medical implants and devices made of biomaterials are in greater demand as the population ages in China. The market is segmented by type and by application. Some key players in this market include Weigao Group, Suzhou Sinomed, MicroPort, BASF SE, Celanese, Covestro AG and Evonik Industries.

ID: IN10CNMD003 CATEGORY: Medical Devices GEOGRAPHY: China AUTHOR: Jigyasu Bhandari

Buy Now

China Biomaterials in Healthcare Market Executive Analysis

The China Biomaterials Healthcare Market size is at around $12.56 Bn in 2022 and is projected to reach $37.62 Bn in 2030, exhibiting a CAGR of 14.70% during the forecast period. Data pertaining to health and family planning reached $46.05 Bn as of December 2022. The previous estimate for November 2022 was $28.02 Bn, so this indicates an increase. The data reached a record low of $0.86 Bn in January 2007 and a peak of $46.05 Bn in December 2022. In 2022, China's health expenditures as a proportion of GDP were 5.4%. China's health expenditure as a percentage of GDP increased from 4.5% of GDP in 2000 to 5.4% of GDP in 2022, increasing at an average annual rate of 1.00%.

Biomaterials can substitute or repair a variety of damaged tissues and organs, including bone, cartilage, skin, and blood vessels. This could improve the quality of life for patients who have chronic illnesses, injuries, or diseases related to ageing. When using biomaterials as drug transporters, drugs can be directed at particular parts of the body and dispersed over time. This could improve the efficacy and safety of treatments for a variety of diseases and conditions. Applying biomaterials to the therapy of wounds can hasten to heal and prevent infections. This could be advantageous for patients recuperating from acute or chronic lesions. Dental implants, crowns, and bridges are just a few of the dental uses where biomaterials are used. The teeth and gums of individuals may look better and perform better as a result of this. Utilizing biomaterials, tissue engineering can produce new organs or cells for transplantation. This may help to solve organ donor scarcity and increase the success rates of transplant operations. Biomaterials are employed in orthopaedic procedures like spine implants, bone grafts, and joint replacements. Patients with musculoskeletal disorders may experience increased mobility and a higher standard of life as a result. Heart valves, pacemakers, and other circulatory devices can all be made of biomaterials. Patients who suffer from cardiovascular diseases or other illnesses may fare better as a result of this.

China Biomaterials Healthcare Market Analysis

Market Dynamics

Market Growth Drivers

One of the world's biggest ageing populations is found in China. Medical implants and devices made of biomaterials are in greater demand as the population ages. More people are choosing to invest in their health by choosing expensive medical treatments as disposable incomes increase. The need for high-quality biomaterials used in implants and medical equipment is fueled by this. In China, cardiovascular illness is becoming more common. These illnesses are treated with the help of biomaterials, which increases the demand for biomaterial producers. Technology development has led to the creation of novel biomaterials that can help patients heal more quickly and with improved results.

Market Restraints

Numerous companies are vying for market share in China's fiercely competitive biomaterials sector. Pricing pressures may result from this, which would reduce the manufacturer's profitability. Due to the high cost of developing biomaterials, smaller biomaterials companies in China may find it challenging to enter the healthcare biomaterials industry. Biomaterials may raise ethical issues that limit their applicability in certain situations, such as stem cell research and tissue engineering.

Competitive Landscape

Key Players

Weigao Group (CN)
Suzhou Sinomed (CN)
MicroPort (CN)
BASF SE
Celanese
Covestro AG
Evonik Industries

Notable Recent Deals

2021: Hygeia Medical Service Group, a top healthcare provider in China that focuses on the creation and production of medical devices and biomaterials, received a $250 million investment from Warburg Pincus in 2021.

2020: The merger of Suzhou Medical, a producer of orthopaedic devices and biomaterials, and MicroPort Scientific, a major producer of medical devices in China, was accomplished for about $105 Mn.

Healthcare Policies and Regulatory Landscape

In China, the National Medical Products Administration (NMPA) is the regulatory authority in charge of regulating the efficacy and safety of medical devices. Before medical devices, including biomaterials, can be distributed in China, they must be registered and approved by the NMPA. The Medical Device Regulations (MDR) were updated in 2021 to better the safety and efficiency of medical devices in China and to be consistent with international norms. New criteria for the registration and certification of medical devices, including biomaterials, are included in the MDR. In China, the National Health Commission (NHC) is in charge of creating healthcare policies and rules. The NHC is crucial in influencing the development of China's healthcare system, including the use of biomaterials in medical equipment. The Chinese government has created a long-term strategy called the Healthy China 2030 Plan to enhance the health and well-being of the Chinese people. Initiatives to raise medical care standards and encourage the use of biomaterials are part of the strategy.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the China market in 2019. The growing geriatric population Chinaly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.